Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Laurie Andrews
Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Once-Daily Lopinavir/Ritonavir
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Related publications
Pharmacokinetic Interactions Between the HCV Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, or Darunavir in Healthy Participants
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Buprenorphine–naloxone
CMAJ
Medicine
Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Lopinavir/Ritonavir Population Pharmacokinetics in Neonates and Infants
British Journal of Clinical Pharmacology
Pharmacology
Abuse Liability of Intravenous Buprenorphine/Naloxone and Buprenorphine Alone in Buprenorphine-Maintained Intravenous Heroin Abusers
Addiction
Medicine
Psychiatry
Mental Health
Comparisons Between Twice-Daily and Once-Daily Training Sessions in Male Weight Lifters
International Journal of Sports Physiology and Performance
Sports Medicine
Physical Therapy
Sports Science
Orthopedics
Sports Therapy
Rehabilitation
Tularemia and Once-Daily Gentamicin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetic Study of Once Daily 800mg Nabumetone in the Middle-Aged and Elderly Patients With RA.
Ensho
Pharmacokinetic Study of Once-Daily Versus Twice-Daily Abacavir and Lamivudine in HIV Type-1-Infected Children Aged 3-<36 Months
Antiviral Therapy
Infectious Diseases
Pharmacology
